Sunitinib-Induced Myositis Detected on 18F-FDG PET/CT.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 35025809.
- Also identified by DOI 10.1097/RLU.0000000000004035.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sunitinib is one of the most commonly used multikinase inhibitors for metastatic renal cell carcinoma. Myositis is one of the rarest known adverse effects of sunitinib. Presenting herewith one such case with its relevant imaging findings on FDG PET/CT and ultrasound.
Medical subject headings
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Myositis